Immuno-Oncology Summit 2025

Biointron is excited to announce our participation in the Immuno-Oncology Summit 2025, taking place in Philadelphia, Pennsylvania, from August 11 - 13, 2025. This premier event brings together leading scientists, clinicians, and industry innovators to explore the latest advances in cancer immunotherapy, from immune checkpoint inhibitors to cell therapies and beyond. 

As a leader in antibody discovery and engineering, Biointron recognizes the transformative potential of immuno-oncology in harnessing the immune system to fight cancer. Our team is dedicated to delivering high-quality, customized antibody solutions that enhance therapeutic efficacy, target precision, and patient safety. 

At the Immuno-Oncology Summit 2025, we look forward to participating in in-depth discussions on next-generation immunotherapies, collaborating with thought leaders, and sharing our expertise in antibody engineering to accelerate breakthroughs in cancer treatment. We invite you to connect with us at booth #1 to discover how Biointron’s innovative antibody solutions can help advance your immuno-oncology programs from concept to clinic. 

For more details about the event, please visit the Immuno-Oncology Summit 2025 website [https://www.immuno-oncologysummit.com/] 

Time: August 11 - 13, 2025 

Location: Philadelphia, Pennsylvania 

Booth: #1